The ADC binds Nectin-4 on tumor cells, is internalized, and releases exatecan, which inhibits DNA topoisomerase I to cause DNA replication arrest and apoptosis. Topoisomerase I is the intracellular payload target, not the cell-surface antigen used for targeting.